| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 126, 2815-2822, Copyright © 1990 by Endocrine Society
ARTICLES |
R D'Ambra, M Surana, S Efrat, RG Starr and N Fleischer
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.
Insulin secretory physiology has been characterized in tumor cell lines derived by primary culture of insulinomas that developed in transgenic mice expressing the large T-antigen of SV40 in pancreatic islet beta- cells. Cells in one of these lines, beta TC-3, contain large amounts of insulin (3100 +/- 294 ng/100 micrograms cellular protein). Constitutive release of insulin over 2 h in static incubation was low at 31.9 ng/100 micrograms protein and was increased 2-fold by glucose (16.7 mM) and 8- fold by depolarizing concentrations of potassium (45 mM). Isobutylmethylxanthine (IBMX; 0.5 mM) and forskolin (5 and 50 microM), which elevated cellular levels of cAMP, were ineffective as secretagogues, but dramatically potentiated glucose and potassium effects on insulin release (6.5- and 4-fold, respectively). A variety of other known insulin secretagogues stimulated insulin release in a manner analogous to their effects in normal islets. The sulfonylurea glipizide (1 microM) and the tumor-promoting phorbol ester 12-O- tetradecanoylphorbol-13-acetate (1 microM) stimulated insulin release 3.4- and 13.7-fold, respectively. The cholinergic agonist carbachol (2 microM) was ineffective alone, but potentiated glucose-induced insulin release 2.8-fold. Comparable stimulation of insulin release by glucose (16.7 mM) and glucose (16.7 mM) plus IBMX (0.5 mM) was noted with several other beta TC lines, which were derived independently from separate transgenic mice. Glucose- and glucose- plus IBMX (0.5 mM)- induced insulin release occurred progressively from 0.15-16.7 mM, indicating that insulin release from beta TC-3 cells occurred at much lower levels than that from normal islets. However, as in the normal islet, the glucose concentration dependency for insulin release was highly correlated (r = 0.93) with the glucose concentration dependency for glucose utilization (measured by 3H2O formation from [5- 3H]glucose). This suggests that glucose induces insulin release from beta TC-3 cells by a mechanism similar to that in the normal islet. The high insulin content, the multifold stimulation of insulin release by a variety of secretagogues, their convenient propagation in culture, and the renewable source of these cell lines make the beta TC cells a convenient model for studies of beta-cell function.
This article has been cited by other articles:
![]() |
M. Hao, W. S. Head, S. C. Gunawardana, A. H. Hasty, and D. W. Piston Direct Effect of Cholesterol on Insulin Secretion: A Novel Mechanism for Pancreatic {beta}-Cell Dysfunction Diabetes, September 1, 2007; 56(9): 2328 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Weinberg, L. Ouziel-Yahalom, S. Knoller, S. Efrat, and Y. Dor Lineage Tracing Evidence for In Vitro Dedifferentiation but Rare Proliferation of Mouse Pancreatic {beta}-Cells Diabetes, May 1, 2007; 56(5): 1299 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liuwantara, M. Elliot, M. W. Smith, A. O. Yam, S. N. Walters, E. Marino, A. McShea, and S. T. Grey Nuclear Factor-{kappa}B Regulates {beta}-Cell Death: A Critical Role for A20 in {beta}-Cell Protection Diabetes, September 1, 2006; 55(9): 2491 - 2501. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Han, P. Sonati, C. Rubin, and T. Michaeli PDE7A1, a cAMP-specific Phosphodiesterase, Inhibits cAMP-dependent Protein Kinase by a Direct Interaction with C J. Biol. Chem., June 2, 2006; 281(22): 15050 - 15057. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hao, X. Li, M. A. Rizzo, J. V. Rocheleau, B. M. Dawant, and D. W. Piston Regulation of two insulin granule populations within the reserve pool by distinct calcium sources J. Cell Sci., December 15, 2005; 118(24): 5873 - 5884. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Arkhammar, P. Wahl, B. Gerlach, T. Fremming, and J. B. Hansen Establishment and Application of in Vitro Membrane Potential Assays in Cell Lines with Endogenous or Recombinant Expression of ATP-Sensitive Potassium Channels (Kir6.2/SUR1) Using a Fluorescent Probe Kit J Biomol Screen, August 1, 2004; 9(5): 382 - 390. [Abstract] [PDF] |
||||
![]() |
K. L. Regnauld, E. Leteurtre, S. J. Gutkind, C. P. Gespach, and S. Emami Activation of adenylyl cyclases, regulation of insulin status, and cell survival by Galpha olf in pancreatic beta -cells Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R870 - R880. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rabinovitch, W. L. Suarez-Pinzon, K. Sooy, K. Strynadka, and S. Christakos Expression of Calbindin-D28k in a Pancreatic Islet {beta}-Cell Line Protects against Cytokine-Induced Apoptosis and Necrosis Endocrinology, August 1, 2001; 142(8): 3649 - 3655. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sooy, T. Schermerhorn, M. Noda, M. Surana, W. B. Rhoten, M. Meyer, N. Fleischer, G. W. G. Sharp, and S. Christakos Calbindin-D28k Controls [Ca2+]i and Insulin Release. EVIDENCE OBTAINED FROM CALBINDIN-D28k KNOCKOUT MICE AND beta CELL LINES J. Biol. Chem., November 26, 1999; 274(48): 34343 - 34349. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Grey, M. B. Arvelo, W. Hasenkamp, F. H. Bach, and C. Ferran A20 Inhibits Cytokine-induced Apoptosis and Nuclear Factor {kappa}B-dependent Gene Activation in Islets J. Exp. Med., October 18, 1999; 190(8): 1135 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Han, J. Werber, M. Surana, N. Fleischer, and T. Michaeli The Calcium/Calmodulin-dependent Phosphodiesterase PDE1C Down-regulates Glucose-induced Insulin Secretion J. Biol. Chem., August 6, 1999; 274(32): 22337 - 22344. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Varlamov, L. D. Fricker, H. Furukawa, D. F. Steiner, S. H. Langley, and E. H. Leiter {beta}-Cell Lines Derived from Transgenic Cpefat/Cpefat Mice Are Defective in Carboxypeptidase E and Proinsulin Processing Endocrinology, November 1, 1997; 138(11): 4883 - 4892. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Z. Zhao, H. Zhao, J. Teague, W. Fujimoto, and J. A. Beavo Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B PNAS, April 1, 1997; 94(7): 3223 - 3228. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Deeg and C. B. Verchere Regulation of Glycosylphosphatidylinositol-Specific Phospholipase D Secretion from {beta}TC3 cells Endocrinology, February 1, 1997; 138(2): 819 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Holz, IV, C. A. Leech, and J. F. Habener Activation of a cAMP-regulated Ca[IMAGE]-Signaling Pathway in Pancreatic [IMAGE]-Cells by the Insulinotropic Hormone Glucagon-like Peptide-1 J. Biol. Chem., July 28, 1995; 270(30): 17749 - 17757. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Philipson, A. Kuznetsov, P. T. Toth, J. F. Murphy, G. Szabo, G. H. Ma, and R. J. Miller Functional Expression of an Epitope-tagged G protein-coupled K[IMAGE] Channel (GIRK1) J. Biol. Chem., June 16, 1995; 270(24): 14604 - 14610. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |